---
title: "OUTRUN THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7
json: https://whiteintel.dev/api/public/dossier/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7
identifier: oo:GB-COH-SC648164
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# OUTRUN THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-SC648164`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7  

## Ownership & control

### Owners / controllers

- **Mitsubishi Chemical Holdings Corporation** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/2d6e757b-573a-4529-afeb-09686415cdf7
- **Mr Satpal Singh Virdee** (beneficial owner) — 50% — https://whiteintel.dev/entity/c7665190-42da-5113-b336-334687c0cdbf
- **UNIVERSITY OF DUNDEE(THE)** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b7130ded-47a6-573a-b356-02ad053876ea
- **Prof Satpal Singh Virdee** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/394f4054-db78-4eb5-9a3d-eb8723270fc4
- **Merck Kommanditgesellschaft Auf Aktien** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/965aaa55-01bc-459d-b027-741c9300a58c

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `SC648164`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2019-11-26
- **Registered office:** Errol Road, Invergowrie, Dundee, DD2 5DA, Scotland
- **SIC:** 86900

### Officers

- ANNINGA, Bauke, Dr — director · Dutch · appointed 2023-11-27
- JOHNSON, Anthony Gerard — director · American · appointed 2022-09-23
- ROBERTS, Christopher, Dr — director · American · appointed 2021-07-14
- VIRDEE, Satpal Singh, Prof — director · British · appointed 2020-11-24
- GOKER, Hakan, Dr — director · British · appointed 2021-04-01 · resigned 2022-09-23
- HAIGH, Robert Merrick, Dr — director · British · appointed 2022-01-01 · resigned 2022-12-02
- MOORE, Jeffrey Bernard — director · Canadian · appointed 2021-04-01 · resigned 2026-07-01
- MUIR, Anne Margaret — director · British · appointed 2019-11-26 · resigned 2020-11-24
- PORTER, Carolyn, Dr — director · British · appointed 2024-02-06 · resigned 2025-12-31
- ZIMBERLIN, Cheryl Doreen — director · Dutch · appointed 2021-04-01 · resigned 2023-11-27

### Beneficial owners (Persons with Significant Control)

- Merck Kgaa — 25–50% shares · corporate PSC · Germany — since 2022-01-22
- [Mitsubishi Chemical Holdings Corporation](https://whiteintel.dev/entity/2d6e757b-573a-4529-afeb-09686415cdf7) — 25–50% shares · corporate PSC · Japan — since 2022-01-22
- Prof Satpal Singh Virdee — 25–50% shares · individual PSC · Scotland — ceased 2022-01-22
- [University Of Dundee (The)](https://whiteintel.dev/entity/b7130ded-47a6-573a-b356-02ad053876ea) — 75–100% shares · corporate PSC · United Kingdom — ceased 2021-03-05

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/SC648164
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/SC648164

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **OUTRUN THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7 · Structured JSON: https://whiteintel.dev/api/public/dossier/ca6b8c96-d5d5-5d32-a8c5-e09f36a0cec7._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._